R. 30  - Prescriptions régissant les demandes de brevet européen portant sur des séquences de nucléotides et d'acides aminés  R. 30 - Requirements of European patent applications relating to nucleotide and amino acid sequences  R.30 - Erfordernisse europäischer Patentanmeldungen betreffend Nucleotid- und Aminosäuresequenzen
EPO internal links
Site map
© T. Bouvier
tous droits réservés
all rights reserved







Rule 30

Requirements of European patent applications relating to nucleotide and amino acid sequences

- OJ 11/2013, 542

- OJ 6/2011, 376



A III 1.2

B IV 1.2



(1) If nucleotide or amino acid sequences are disclosed in the European patent application, the description shall contain a sequence listing conforming to the rules laid down by the President of the European Patent Office for the standardised representation of nucleotide and amino acid sequences.

- OJ 6/2011, 372

- OJ 5/2010, 328

- OJ 5/2010, 330

A IV 5.



(2) A sequence listing filed after the date of filing shall not form part of the description.


A IV 5.

H IV 2.3.4



(3) Where the applicant has not filed a sequence listing complying with the requirements under paragraph 1 at the date of filing, the European Patent Office shall invite the applicant to furnish such a sequence listing and pay the late furnishing fee. If the applicant does not furnish the required sequence listing and pay the required late furnishing fee within a period of two months after such an invitation, the application shall be refused.

Art. 121

Art. 122:NO

A IV 5.









See decision of the President of the EPO and the Notice from the EPO, Special edition No. 3, OJ EPO 2007, C.1. and C.2.







Related provisions

Case Law






Art. 56

Art. 57

Art. 80


R. 42


BoA decisions